Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3827314 | Progrès en Urologie | 2009 | 6 Pages |
Abstract
In spite of a reputedly bleak prognosis, primitive MNHL of the testicle treated with a combination of systemic and intrathecal chemotherapy would seem to be associated with a good specific long-term survival. Unfortunately, the rate of mortality linked to chemotherapy is significant (close to 12.5% in our series) and would not appear to entirely protect against cerebral recurrence.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
C. Sénéchal, F. Saint, T. Petit, J. Petit,